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Objectives:This study assessed the predictive value of histologic plaque characteristics for the occurrence of restenosis after
femoral artery endarterectomy.
Background: It would be advantageous if patients at increased risk for restenosis after arterial endarterectomy could be
identified by histologic characteristics of the dissected plaque. Differences in atherosclerotic plaque composition of the
carotid artery have been associated with restenosis rates after surgical endarterectomy. However, whether atherosclerotic
plaque characteristics are also predictive for restenosis in other vascular territories is unknown.
Methods: Atherosclerotic plaques of 217 patients who underwent a common femoral artery endarterectomy (CFAE; n 
124) or remote superficial femoral artery endarterectomy (RSFAE; n 93) were examined and scored microscopically for
the presence of collagen, macrophages, smooth muscle cells, lipid core, intraplaque hemorrhage, and calcifications. The
12-month restenosis rate was assessed using duplex ultrasound imaging (peak systolic velocity [PSV] ratio >2.5).
Results:The 1-year restenosis rate was 66% (61 of 93) after RSFAE compared to 21% (26 of 124) after CFAE. Plaque with
characteristics of high collagen and smooth muscle cell content were positively associated with the occurrence of
restenosis, with odds ratios (ORs) of 2.90 (95% confidence interval [CI], 1.82-4.68) and 2.20 (1.50-3.20) for superficial
femoral artery (SFA) and common femoral artery (CFA), respectively. SFA plaques showed significantly heavier staining
for collagen (69% vs 31% for CFA; P< .001) and smooth muscle cells (64% vs 36% for CFA; P< .001). After multivariate
analysis, the operation type (CFAE or RSFAE), gender, and the presence of collagen were independent predictive
variables for restenosis after endarterectomy of the CFA and SFA.
Conclusion: Plaque composition of the CFA and SFA differs. Furthermore, the dissection of a fibrous collagen-rich
plaque is an independent predictive variable for restenosis after endarterectomy of the CFA and SFA. ( J Vasc Surg
2010;52:592-9.)Prevention and risk management of restenosis after
endarterectomy of the peripheral arteries represents one of
the major challenges in peripheral revascularization. Extent
of the disease, number of run-off arteries, and diabetes
mellitus are known risk factors after peripheral vascular
intervention.1,2 In contrast with established risk factors, the
relation between local atherosclerotic plaque characteristics
and the development of restenosis after femoral artery
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592endarterectomy has never been studied. It would be advan-
tageous if patients at risk for restenosis could be identified
directly after surgery by examining the dissected plaque.
Atherosclerotic plaque composition of the carotid ar-
tery has been associated with restenosis after surgical end-
arterectomy. Macrophage infiltration and a large lipid core
in the dissected carotid plaque were independent predictive
parameters for lower restenosis rates after carotid endarter-
ectomy.3 However, whether atherosclerotic plaque charac-
teristics are also predictive for restenosis in other vascular
territories is unknown.
This study was conducted to determine whether histo-
logic plaque characteristics of the femoral artery are predic-
tive for the occurrence of restenosis after endarterectomy.
METHODS
Patient population. The studied patient population
was a subgroup of patients who were included in the
Athero-Express Biobank. The subgroup consisted of all
patients who underwent a sole common femoral artery
endarterectomy (CFAE) or remote superficial femoral ar-
tery endarterectomy (RSFAE). The design of the Athero-
Express Biobank has been described previously.4 Briefly,
ty C
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longitudinal study design. The main objective is to deter-
mine the predictive value of local atherosclerotic plaque
characteristics for the occurrence of future local and sys-
temic cardiovascular events. Dissected femoral plaques,
freshly obtained during endarterectomy in two participat-
ing Dutch hospitals, were collected and underwent histo-
logic examination. In addition, clinical follow-up was ob-
tained 1 to 3 years after the surgical intervention.
In both hospitals, patients with peripheral leg ischemia
are being treated by use of the same protocol (Fig 1). First,
patients with intermittent claudication are treated conser-
vatively with supervised walking exercise. Patients without
improvement and disabling complaints, or whose com-
plaints worsen after supervised exercise, and patients with
critical ischemia primarily are discussed in a multidisci-
plinary meeting with interventional radiologists and vascu-
lar surgeons. Patients with a sole lesion (TransAtlantic
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Fig 1. Treatment protocol of patients with periphera
hospitals, patients with peripheral leg ischemia are being
diagram are the studied patients.CFA,Common femoral
great saphenous vein; PI, percutanous intervention; RSF
supficial femoral artery; TASC, TransAtlantic Inter-SocieInter-Society Consensus [TASC] A and B lesions) of thecommon femoral artery (CFA) are treated with endarterec-
tomy and closed with patch plasty (Fig 1).
TASC C lesions of the superficial femoral artery (SFA),
assessed as not treatable by percutaneous intervention, and
TASC D lesions of the SFA are treated with a venous
supragenicular bypass. A patient who does not have a
suitable great saphenous vein will be treated primarily with
RSFAE (Fig 1). If the RSFAE fails, patients undergo pros-
thetic supragenicular bypass.
The current study selected the 238 patients who under-
went a CFAE (TASC A and B lesions) or RSFAE (TASC C
and D lesions) to treat severe intermittent claudication,
critical ischemia, or tissue loss (Rutherford classification
II-VI) from June 2002 until October 2007. Surgical pro-
cedures were performed in a standardized way, as described
previously.5,6 Clinical characteristics of all patients were
prospectively recorded at baseline, their medical records
were studied, and the patients completed a detailed vali-
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AE,dated questionnaire. The medical ethics boards of both
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provided written informed consent.4
Plaque characteristics. The procedures for processing
and examination of the dissected atherosclerotic plaques have
been described previously.4 Directly after excision, the ath-
erosclerotic plaque was transferred to the laboratory. Ac-
cording to the literature, we chose the segment with the
greatest plaque burden as the culprit lesion. When the
femoral plaque was totally occluded, we chose the most
voluminous and intact part of the plaque.4 The culprit
lesion was fixed in 4% formaldehyde, decalcified in ethyl-
enediaminetetraacetic acid, and embedded in paraffin. Seg-
ments adjacent to the culprit lesion were snap frozen in
liquid nitrogen and stored at 80°C for future analysis.
The paraffin segment of the culprit lesion was cut on a
microtome into sections of 5 m for histologic and immu-
nohistochemical staining and the following stainings were
performed to characterize the plaque: picrosirius red (col-
lagen and lipid core), CD 68 (macrophages), -actin
(smooth muscle cells), hematoxylin and eosin (calcifica-
tion, lipid core, and intraplaque hemorrhage), and fibrin
(intraplaque hemorrhage). All stainings were examined mi-
croscopically, and plaque characteristics were scored semi-
quantitatively (no/minor vs moderate/heavy). The defini-
tions of each staining category have been published
previously.4 All scorings were based on visual estimates and
were rated on ordinal scales. Two observers independently
scored all stainings. A third independent observer was
consulted when interpretations differed between the first
two observers. Briefly, “no or minor” represent absent or
minimal staining with a few clustered cells, whereas “mod-
erate and heavy” represent larger areas of positive staining.4
Before determination of the different histologic char-
acteristics, we differentiated between the intima and media
in the hematoxylin and eosin and elastin von Gieson stain-
ing by deciding where the internal elastic lamina was lo-
cated. The studied histologic characteristics are only scored
in the intimal layer.4,7
No or minor macrophage and smooth muscle cell
infiltration is shown by absent or minimal staining with few
clustered cells, whereas moderate and heavy infiltration is
shown by moderate or heavy staining with larger areas of
clustered cells. No or minor collagen content is shown by
absent or minimal staining for collagen with a thin fibrous
cap, whereas moderate or heavy collagen is shown by
moderate staining or heavy staining for collagen, covering
any lipid in the atherosclerotic lesion, as visualized with and
without polarized light. No or minor calcifications are
indicated by absent or nonconfluent speckled areas of
plaque calcification, whereas moderate or heavy represent
nodules of calcified plaque or confluent areas of calcified
plaque, respectively.
Intraplaque hemorrhage was scored as present or ab-
sent. The size of the lipid core was estimated as a percentage
of the total plaque area with a division in three categories:
none, 40%, and 40%. We have recently demonstrated
that our semiquantitative analysis of atherosclerotic plaque
histology is well reproducible, both intraobserver and in-terobserver variability.7 CD-68 and -actin stains were also
analyzed quantitatively, and these values revealed excellent
correlations with our semiquantitative analyses.7
Follow-up. Follow-up of the patients was scheduled
at 3, 6, and 12 months, and annually thereafter, and in-
cluded medical history, physical examination, and duplex
ultrasound scanning. Duplex ultrasound scanning to detect
restenotic lesions was performed according to protocol.
The entire CFA, the proximal profunda femoral artery, the
entire SFA (from origin to the popliteal artery, including
the distal stent after RSFAE), and the entire popliteal artery
were scanned in every patient. Obstructions were classified
on the basis of the peak systolic velocity (PSV) within the
obstruction (numerator of the PSV ratio) and proximally of
the obstruction (denominator of the PSV ratio). A stenosis
of 50% was considered if the PSV ratio was 2.5. The
endpoint of this study was restenosis 12 months postoper-
atively, which was assessed by duplex ultrasound imaging.
Lumen reduction of 50% using duplex ultrasound imag-
ing (PSV ratio 2.5) was considered as the presence of
significant postoperative restenosis.
Data analysis. Statistical analysis was performed with
SPSS 15.0 software (SPSS Inc, Chicago, Ill). Univariate
analysis was used to test baseline characteristics for associ-
ation with restenosis. Categoric variables were tested using
cross tables (2  2), and the accompanying P value was
calculated with the 2 statistic. Continuous variables were
tested nonparametrically by using the Mann-Whitney U
test. P values .05 were considered statistically significant.
To test independency of the univariate variables, multivar-
iate binary logistic regression analysis (with backward ex-
clusion of nonsignificant variables using likelihood ratio
test) was performed. Variables showing a significant associa-
tion with restenosis in univariate analysis were included in the
multivariate analysis. Age, gender, and operation indication
were always included in the multivariate analysis models.
RESULTS
A total of 238 patients underwent a CFAE or RSFAE.
Excluded from the study were two patients who died in the
first postoperative month of coronary artery disease and 19
patients whose atherosclerotic plaque material was insuffi-
cient for histologic analyses. Therefore, a total 217 patients
were examined for the current study.
CFAE was done in 124 patients (57%) and RSFAE in 93
patients (43%). Of the 217 patients, 168 (77%) were operated
on for intermittent claudication (Rutherford class III). The
other patients had critical ischemia or tissue loss (Rutherford
class IV-VI).Men comprised 73%of the patientswho received
surgery, and most patients were affected by risk factors for
atherosclerotic disease, as summarized in Table I.
Most of the atherosclerotic plaques were fibrotic, 85%
contained moderate (n  114) to heavy (n  74) staining
for collagen, 75% had moderate (n 90) to heavy (n 73)
staining for smooth muscle cells, and 69% had moderate
(n  46) to heavy (n  104) staining for calcifications.
Macrophage staining was only moderate (n  36) to heavy
(n  7) in 20%, and a lipid core was present in 25% of the
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65% of all plaques (n  141).
Duplex ultrasound examinations revealed a restenosis
(50% lumen reduction) in 87 patients (40%) 12 months
postoperatively. Restenosis was present in 56% of women
(33 of 59) compared to 34% of men (54 of 158), which was
significant. Current smoking was also significantly associ-
ated with restenosis (Table I). Restenosis rates were signif-
icantly higher in patients who underwent an RSFAE com-
pared to CFAE (61 of 93 [66%] vs 26 of 124 [21%],
respectively; Table I). Restenosis occurred after RSFAE in
61 patients. Of these, 38 patients (62%) were symptomatic
and needed a reintervention, which consisted of percutane-
ous transluminal angioplasty in 25, a bypass graft in 11, and
open repeat endarterectomy of the proximal SFA with
proximal patch plasty in 2. Of the 26 patients with resteno-
sis after CFAE, 4 (15%) needed reintervention, 3 were
treated with a repeat endarterectomy of the CFA with
proximal patch plasty, and 1 patient was treated with a
renewed bypass graft.
In univariate analyses, the presence of collagen and
smooth muscle cells were significantly (P  .001) associ-
ated with restenosis (Fig 2). The risk that stenosis would
develop was higher in patients with moderate or heavy
collagen or smooth muscle cell staining in their plaque with
odds ratios (ORs) of 2.90 (95% confidence interval [CI],
1.82-4.68) and 2.20 (95% CI, 1.50-3.20), respectively,
than in patients who showed no or minor staining of
collagen or smooth muscle cells in their femoral plaque. In
addition, heavy staining for calcification was inversely re-





Age; mean (SD) 67 (9.0)
Gender
Male 158/217 (73) 104/
Female 59/217 (27) 26
Operation Indication
Rutherford class III 168/217 (77) 95/
Rutherford class IV 26/217 (12) 18
Rutherford class V-VI 23/217 (11) 17
Operation type/operated artery
CFAE 124/217 (57) 98/
RSFAE 93/217 (43) 32
Hypertension 158/217 (73) 98/
Hypercholesterolemia 154/217 (71) 91/
Diabetes mellitus 67/217 (31) 39
Current smoker 83/217 (38) 42
Serum creatinine; mean (SD) 99 (56)
Myocardial infarction in past 70/217 (32) 43
Cerebrovascular event in past 26/217 (12) 15
Statin use 170/217 (78) 99/
Aspirin use 175/217 (81) 107/
CFAE, Common femoral artery endarterectomy; CI, confidence interval; n
*Data are presented as No. (%) unless otherwise indicated.
†Age per 10 years.
‡Creatinine per 20 mg/dL.
§P  .05.lated (P  .001) with restenosis rates (OR, 0.67; 95% CI,0.53-0.86). The presence of macrophages, lipid core, or
intraplaque hemorrhage was not related with restenosis
development (Fig 2).
Of the total 87 patients with restenosis (50% lumen
reduction with duplex ultrasound scan) 12 months postop-
eratively, 5 patients were detected with a restenosis by
ultrasound duplex scan at 3 months, another 36 patients at
6 months, and another 46 patients at their 12-month
follow-up. We could not show a significant difference in
plaque histology between patients suffering from early re-
stenosis (6 months) compared with patients suffering
from late (6 months) restenosis (data not shown).
When the histologic plaque characteristics between the
CFA and SFA were compared, staining for calcification,
collagen, and smooth muscle cells differed significantly
between the two femoral arteries (Fig 3). Moderate to
heavy staining for collagen was significantly more prevalent
in the SFA (89 of 93 [96%]) compared to the CFA (99 of
124 [80%]; P  .001). Moderate to heavy staining for
smooth muscle cells also seemed more prevalent in the SFA
(83 of 93 [89%]) compared to the CFA (80 of 124 [65%];
P  .001). Moderate to heavy calcifications were signifi-
cantlymore present in the CFA (94/124 [76%]) than in the
SFA (56 of 93 [60%]; P .001). Intraplaque hemorrhage,
lipid core, and macrophages did not differ significantly
between the CFA and SFA plaques (Fig 3).
Collagen, calcification, or smooth muscle cell content
in the plaque did not correlate with the presence or absence






(95% CI) P value
9.3) 67 (8.5) 0.82 (0.62-1.10)
†
.19
66) 54/158 (34) 0.41 (0.22-0.75) .004
§
44) 33/59 (56) — —
57) 73/168 (44) Reference
69) 8/26 (31) 0.58 (0.24-1.40) .23
74) 6/23 (26) 0.46 (0.17-1.22) .12
79) 26/124 (21) 0.14 (0.08-0.26) .001
§
34) 61/93 (66) — —
62) 60/158 (38) 0.73 (0.40-1.33) .30
59) 63/154 (41) 1.13 (0.62-2.05) .70
58) 28/67 (42) 1.11 (0.62-1.99) .73
51) 41/83 (49) 1.87 (1.07-3.27) .03
§
65) 99 (41) 1.04 (0.85-1.28)
‡
.71
61) 27/70 (39) 0.91 (0.51-1.63) .75
58) 11/26 (42) 1.11 (0.48-2.55) .81
58) 71/170 (42) 1.39 (0.71-2.73) .34
61) 68/175 (39) 0.77 (0.39-1.52) .45
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were independent predictors for restenosis, we performed a
multivariate analysis. The initial variable set consisted of
Fig 2. Plaque characteristics in relation to restenosis. D
endarterectomy of the femoral arteries. A, collagen; (B)
calcification; (F) intraplaque hemorrhage. *P  .001.gender, age, severity of ischemia, operation (CFAE orRSFAE), collagen, smooth muscle cells, heavy staining for
calcification, and current cigarette smoking. Type of oper-
ation (CFAE or RSFAE), collagen staining, and gender
ent plaque characteristics in relation to restenosis after
core; (C) macrophages; (D) smooth muscle cells; (E)iffer
lipidwere independent predictive parameters for restenosis de-
s. *P
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cohort, there was no interaction between collagen and type
of artery or between collagen and gender.
DISCUSSION
This is the first study, to our knowledge, that provides
Fig 3. Plaque characteristics in relation to operation (
superficial femoral artery endarterectomy [RSFAE]). Di
(CFA) and the superficial femoral artery (SFA). A, lip
collagen; (E) smooth muscle cells; and (F) macrophageevidence that histology of the dissected femoral plaquehides predictive value for risk of restenosis after CFAE and
RSFAE. Logically, the operation type is a strong indepen-
dent predictor for restenosis: CFAE and RSFAE are differ-
ent surgical techniques, and RSFAE is performed for TASC
C/D lesions, while CFAE for TASC A/B. However, when
we corrected for the operation type, and inherent to this for
on femoral artery endarterectomy [CFAE] or remote
t plaque characteristics for the common femoral artery
re; (B) intraplaque hemorrhage; (C) calcification; (D)
 .001.comm
fferen
id cothe different TASC lesions, moderate to heavy staining of
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dent variable for restenosis. Furthermore, we observed that
the histologic plaque characteristics differ between the CFA
and SFA.
Reported restenosis rates seem high in this study com-
pared to other literature.5,8 Published studies on CFAE or
RSFAE reported primary patency rates, which is defined as
uninterrupted patency without any procedures performed
on the target lesion. We reported restenosis rates and
scored all patients with a lumen reduction of 50% or more
as restenotic lesion, although a substantial number of
asymptomatic patients were treated conservatively.
A recent published article of our group showed that the
inflammatory unstable carotid plaques with high content of
macrophages and a large lipid core were associated with less
restenosis, probably due to inflammatory activity in the
vascular wall, which elicits expansive remodeling.3 In this
study, we determined that the fibrotic (stable plaque) fea-
tures of femoral artery plaques, like collagen and smooth
muscle cells, were associated with a higher incidence of
restenosis, whereas the inflammatory plaque characteristics
were not. Although these results may suggest conflicting
observations between the carotid and femoral artery with
respect to restenosis prediction, the observation supports
the underlying concept that stable plaques are associated
with a higher restenosis rate. The different plaque charac-
teristics (eg, low content of macrophages and absence of a
lipid core vs high collagen and smooth muscle cell content)
are considered determinants of the same plaque type: the
stable fibrous plaque.
It has been demonstrated that inflammatory carotid
plaque characteristics are less prevalent in patients with a
longer time interval between the clinical onset of symptoms
(eg, stroke) and carotid endarterectomy.9 Owing to the
current treatment policy of supervised walking exercise
after the start of intermittent claudication, patients are
often operated on several years after the initiation of isch-






Male 0.33 (0.15-0.69) .003
Female —
Operation type/operated artery
CFAE 0.02 (0.00-0.17) .001
RSFAE —
Collagen 1.87 (1.03-3.37) .038
Smooth muscle cells 0.69 (0.34-1.38) .29
Interaction smooth muscle
cells - type of artery (CFA
or SFA) 0.02 (1.16-7.20) .02
Calcification (heavy staining) 0.53 (0.26-1.07) .075
CFA, Common femoral artery; CFAE, common femoral artery endarterec-
tomy; RSFAE, remote superficial femoral artery endarterectomy; SFA, su-
perficial femoral artery.
*With backward exclusion of nonsignificant variables using log-rank test.emic complaints, whereas carotid endarterectomy generallyoccurs within 1 month after the first ischemic event. This
may partly explain why inflammatory characteristics in the
femoral plaque were much less prevalent than fibrous char-
acteristics.
We can only hypothesize about the mechanism for
the increased restenosis rates when fibrous, collagen-rich
plaques have been dissected. Previously, fibrotic character-
istics of the femoral plaque have been associated with
constrictive remodeling (arterial shrinkage or negative re-
modeling). Postmortem studies have demonstrated that
constrictive remodeling is an important determinant of
lumen decrease in the femoral artery.10 In addition, femoral
and coronary arteries with the smallest vessel area encom-
pass plaques that show fewer inflammatory cells and are
more fibrous.11-13 Other studies described that collagen
accumulation results in arterial shrinkage analogous to scar
constriction.14 A likely assumption is that the occluded
femoral artery will shrink over time due to fibrotic remod-
eling, subsequently resulting in a smaller lumen area after
intervention and increased restenosis rates.
To our knowledge, this is the first study showing dif-
ferences in plaque phenotype between the CFA and SFA.
The SFA plaques contained significantly more collagen
compared to the CFA plaques, and this characteristic was
associated with different restenosis rates between these
arteries. Our results may also have implications for other
vascular territories. For instance, it is appreciated that the
left anterior descending coronary artery is more prone for
restenosis after intervention than the other coronary arter-
ies.15 The reason for this remarkable difference is not clear.
One hypothesis is that, like the femoral and carotid arteries,
the difference in patency rates after intervention of other
vascular territories may also be associated with differences
in plaque characteristics.
It is known from literature that race is of influence on
atherosclerotic disease. For example, blacks have larger
coronary lumen and areas enclosed by internal elastic lam-
ina compared with whites, and Indian Asians have less
lower limb atherosclerosis than Europeans, unexplained by
established risk factors.16,17 Because only white Europeans
were included in this study, we can only speculate that race
will be of influence on histologic femoral plaque findings.
Study limitations. This study had several limitations.
First, we can only speculate about the possibility of arterial
shrinkage (negative remodeling) as an explanation for the
current observations. Future research has to confirm our
hypothesis that constrictive remodeling and subsequently
reduced vessel size and residual lumen are reasons for lower
patency rates after endarterectomy. Second, we included
patients operated on with two different techniques (CFAE
and RSFAE), and inherent to these operations, the TASC
lesions that were operated on were also different. However,
this is intrinsic to the different arteries that were operated
on, and besides, we corrected for this in the multivariate
analysis.
Third, according to our study design, we defined the
lesion with the greatest plaque burden as the culprit lesion.4We assume that this is the most representative lesion of the
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single patient. The assumption that the histology of the
culprit lesion is consistent in the total plaque might be a
study limitation.
This study has multiple clinical applications. To our
knowledge, this is the first study to prove that femoral
plaque histology could predict increased risk of restenosis
after endarterectomy. Furthermore, it has been determined
that plaque histology differs between the common and
superficial femoral artery. This may point to new clues for
the understanding of the mechanisms of predicting and
preventing restenosis in both arterial territories.
Besides, individual risk assessment for restenosis is
needed to improve patency rates after femoral endarterec-
tomy. The new concept that plaque histology can predict
restenosis rates, will likely contribute to this. Fourth, our
results can be helpful for developing strategies for incorpo-
rating imaging of atherosclerotic plaques into clinical trials.
The authors are convinced that structural histologic
analysis of the dissected femoral plaque could be an impor-
tant factor for predicting restenosis after endarterectomy.
Restenosis after femoral endarterectomy is still a major
complication. Using histologic plaque characteristics for
the prediction of restenosis is a new concept. Together with
other risk factors, plaque histology could be of influence on
the intensity of the follow-up scheme of the individual
patient.
This study will certainly influence the indication for
RSFAE. We may conclude that women with collagen-rich
plaques should be considered as high-risk patients for re-
stenosis post-RSFAE, and venous bypass grafting is the
preferred operation for this subgroup. When venous mate-
rial is lacking, we think that women can be treated by
RSFAE, but they require more stringent follow-up to iden-
tify early restenosis.
CONCLUSION
Plaque composition of the CFA and SFA differs. Fur-
thermore, the presence of a fibrous collagen-rich athero-
sclerotic plaque is an independent predictive variable for
restenosis after CFAE and RSFAE.
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